Astex Technology is a structure-based drug discovery company that focuses on high throughput X-ray crystallography (HTX®) technology for drug discovery. Astex’ screening approach utilizes protein crystal structures to detect the binding of drug fragments. The company’s integrated drug discovery platform of HTX® technology focuses on all aspects of structure-based research including protein production, crystallization, structure determination, bioinformatics and computational and medicinal chemistry. Astex focuses its drug discovery approaches on proprietary and public domain protein targets from families and/or pathways including kinases, phosphatases and proteases that are implicated in human diseases.